From blind spots to breakthroughs: Gain the gross-to-net clarity you need to lead

How much revenue are you leaving on the table because you weren't first to market? In life sciences, speed isn't optional — it's the difference between leading the market and losing it. Your ability to plan pricing, contracting, and rebate strategies in real time can make or break profitability. But fragmented systems and rigid tools slow down decision-making and erode confidence.

When you can't see the full picture, you can’t act fast, and that can cost you millions. Just a small shift in discounting, chargebacks, or market access terms can swing your margins, but without clear cross-functional visibility, key opportunities could disappear before you even see them. Because while your teams scramble to align pricing strategies for a launch, a more agile competitor could move first — leaving you with millions in lost revenue. 

Anaplan gives finance and commercial teams a faster, smarter way to plan with flexible scenario and analysis planning that links gross-to-net (GTN) assumptions to revenue outcomes. The result: sharper decisions, better timing, and fewer missed opportunities.

Gross-to-net planning challenges that threaten profitability

Life sciences companies with inadequate visibility and insight face significant GTN hurdles that threaten their bottom line:

• Poor data visibility increases risk of errors and miscalculations  
  Fragmented data and manual processes have teams spending hours reconciling data from spreadsheets, emails, and shared drives. These standalone systems struggle to adapt to evolving business rules, increasing risk of errors. 
• Forecast inaccuracy undermines revenue planning and investor confidence  
  Customer and contract-specific discount variations complicate net sales predictions. Discrepancies between bottom-up and top-down forecasts, coupled with manual pricing adjustments, undermine accuracy.
• Compliance risks and uncertain profitability from contract complexity  
  Amid complex contract and regulatory terms, limited access to pricing data hinders modeling of discounts and government pricing, raising compliance risks and reducing confidence in profitability forecasts.
• Inability to model scenarios limits strategic response to market shifts  
  Dynamic market conditions demand robust scenario modeling, but inadequate tools lead to reactive decisions and missed opportunities to optimize strategies.
• Manual reporting blocks visibility and delays critical decisions  
  Manual reporting is inefficient, time-consuming and obscures insights into products, customers, or market conditions — limiting strategic decision-making.

Adopt a modern approach to gross-to-net planning 

Anaplan’s cloud-based planning platform transforms GTN management into a strategic asset by connecting data, processes, and teams across the enterprise. This integration enables organizations to gain deeper insight into GTN performance, helping drive more profitable revenue growth. At the same time, greater transparency supports financial efficiency by identifying and reducing sources of revenue loss and operational waste. With automated workflows and real-time visibility, teams are freed from manual processes and can focus their efforts on high-impact, strategic initiatives.

Why Anaplan for life sciences?

Anaplan puts strategy into action across the GTN lifecycle, empowering you to: 

• Integrate data effortlessly   
  Seamless integration ensures your planning models stay current and accurate —improving decision speed and confidence. Anaplan Data Orchestrator integrates ERP, SAP, IQVIA, and other sources, cutting implementation time by up to 50%.
• Streamline planning processes  
  Efficient processes reduce manual effort and eliminate bottlenecks, enabling faster, more reliable execution. Automated workflows and visual flow charts minimize errors and free teams to focus on strategic tasks. 
• Forecast with confidence  
  Granular, bottom-up forecasting aligns pricing and discounts with market demand. The Polaris™ calculation engine enables rapid, multidimensional predictions at brand, SKU, or channel levels, bridging forecast gaps.
• Master complex contracts  
  Polaris models complex “what-if” scenarios, while Anaplan PlanIQ™ delivers intelligent, accurate forecasts. Together, they enable real-time planning of discounts and regulatory terms, boosting forecast accuracy by up to 70%, and reducing compliance risk.
• Anticipate market shifts  
  Dynamic modeling and multi-dimensional scenario planning and analysis tests pricing and contracting scenarios, analyzing billions of data points to support proactive decisions in volatile markets. 
• Unlock actionable insights  
  Interactive dashboards and automated reporting provide portfolio-wide visibility. Drill-down capabilities empower finance leaders to analyze performance by product or customer, enhancing collaboration. 

Delivering real world customer results

Anaplan delivers transformative results for leading life sciences companies: 

• Global pharma automates 90% of tasks and reduces manual errors  
  A global pharmaceutical company revolutionized its GTN planning with Anaplan, achieving dramatic improvements in forecast accuracy and slashing manual data entry by 90%. By automating processes and enabling real-time scenario analysis, the company empowered its finance team to focus on strategy, reducing errors and enhancing control.
• Multinational pharma aligns strategy and execution across 50+ products  
  A multinational pharma company managing $14B+ in revenue across 50+ products cut planning cycle times by 50% and manual effort by 90% with Anaplan. Real-time, multi-scenario analysis aligns go-to-market assumptions with financial outcomes, driving transparency, and strategic decisions. 

Gross-to-net: Driving financial precision in life sciences

GTN management is a strategic lever that drives commercial success, optimizes supply chains, and enhances company valuation. And an integrated scenario planning and analysis platform empowers finance leaders, like yourself, to unlock millions in revenue, reduce costs, and achieve unparalleled profitability.